ZA201401335B - Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals - Google Patents
Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticalsInfo
- Publication number
- ZA201401335B ZA201401335B ZA2014/01335A ZA201401335A ZA201401335B ZA 201401335 B ZA201401335 B ZA 201401335B ZA 2014/01335 A ZA2014/01335 A ZA 2014/01335A ZA 201401335 A ZA201401335 A ZA 201401335A ZA 201401335 B ZA201401335 B ZA 201401335B
- Authority
- ZA
- South Africa
- Prior art keywords
- chroman
- thiazoles
- yloxy
- pharmaceuticals
- substituted
- Prior art date
Links
- XFZODDHRWKDGLV-UHFFFAOYSA-N 2-(3,4-dihydro-2h-chromen-6-yloxy)-1,3-thiazole Chemical class C1=C2CCCOC2=CC=C1OC1=NC=CS1 XFZODDHRWKDGLV-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2011/065712 WO2013037388A1 (fr) | 2011-09-12 | 2011-09-12 | Thiazoles à substitution 2-(chroman-6-yloxy) et leur utilisation comme produits pharmaceutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201401335B true ZA201401335B (en) | 2015-08-26 |
Family
ID=44645708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2014/01335A ZA201401335B (en) | 2011-09-12 | 2014-02-21 | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
Country Status (8)
| Country | Link |
|---|---|
| KR (1) | KR101817925B1 (fr) |
| AU (1) | AU2011376746B2 (fr) |
| CA (1) | CA2846347C (fr) |
| IL (1) | IL231096A (fr) |
| MA (1) | MA35814B1 (fr) |
| SG (1) | SG11201400518RA (fr) |
| WO (1) | WO2013037388A1 (fr) |
| ZA (1) | ZA201401335B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4100023A4 (fr) * | 2020-02-07 | 2024-03-13 | University of South Florida | Inhibition de l'oligomérisation de la bêta-arrestine en tauopathie |
| KR102863448B1 (ko) | 2022-10-24 | 2025-09-24 | 고려대학교 산학협력단 | 별아교세포의 미세아교세포 내 칼슘 항상성 조절 용도 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4168380A (en) | 1978-04-21 | 1979-09-18 | Hoffmann-La Roche Inc. | 7-Methoxy-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid |
| JPH0967336A (ja) | 1995-09-04 | 1997-03-11 | Kanebo Ltd | 新規なイソチオウレア誘導体 |
| DE69810606T2 (de) | 1997-03-27 | 2003-10-09 | Taisho Pharmaceutical Co., Ltd. | 2-phenoxyanilinderivate |
| AU779908B2 (en) | 1999-09-10 | 2005-02-17 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| WO2002032883A1 (fr) | 2000-10-18 | 2002-04-25 | Senju Pharmaceutical Co., Ltd. | Nouveau derive de 4-benzyloxyphenyle et utilisation de ce derive |
| FI20011507A0 (fi) | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
| WO2004000813A1 (fr) | 2002-06-25 | 2003-12-31 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de phenoxypyridine ou sel de ce derive |
| FI20030030A0 (fi) | 2003-01-09 | 2003-01-09 | Orion Corp | Uusia yhdisteitä |
| JP5092111B2 (ja) | 2007-02-05 | 2012-12-05 | トーアエイヨー株式会社 | ブトキシアニリン誘導体 |
| EP2103939A1 (fr) | 2008-03-20 | 2009-09-23 | sanofi-aventis | Analyse à base de fluorescence pour détecter les composés de modulation de mode inversé (NCX) d'échangeur de sodium/calcium |
| US8354454B2 (en) | 2008-10-01 | 2013-01-15 | Merck Sharp & Dohme Corp. | Prodrugs of oxazolidinone CETP inhibitors |
-
2011
- 2011-09-12 SG SG11201400518RA patent/SG11201400518RA/en unknown
- 2011-09-12 KR KR1020147009758A patent/KR101817925B1/ko not_active Expired - Fee Related
- 2011-09-12 CA CA2846347A patent/CA2846347C/fr not_active Expired - Fee Related
- 2011-09-12 WO PCT/EP2011/065712 patent/WO2013037388A1/fr not_active Ceased
- 2011-09-12 AU AU2011376746A patent/AU2011376746B2/en not_active Ceased
-
2014
- 2014-02-21 ZA ZA2014/01335A patent/ZA201401335B/en unknown
- 2014-02-23 IL IL231096A patent/IL231096A/en active IP Right Grant
- 2014-03-12 MA MA36819A patent/MA35814B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA35814B1 (fr) | 2014-12-01 |
| IL231096A (en) | 2017-07-31 |
| KR20140063807A (ko) | 2014-05-27 |
| KR101817925B1 (ko) | 2018-01-12 |
| CA2846347A1 (fr) | 2013-03-21 |
| AU2011376746B2 (en) | 2017-06-15 |
| CA2846347C (fr) | 2019-05-21 |
| AU2011376746A1 (en) | 2014-03-20 |
| SG11201400518RA (en) | 2014-04-28 |
| IL231096A0 (en) | 2014-03-31 |
| WO2013037388A1 (fr) | 2013-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201401434B (en) | Heterocyclic compounds and uses thereof | |
| IL230536A0 (en) | Heterocyclic compounds and their uses | |
| EP2678016A4 (fr) | Composés hétérocycliques et leurs utilisations | |
| GB201111705D0 (en) | Compounds and their use | |
| IL231082A (en) | Pyrimido compounds - pyridazinone and their use | |
| SG11201403852UA (en) | Fused pyrroledicarboxamides and their use as pharmaceuticals | |
| IL250370A0 (en) | Propionic acid derivatives substituted with heteroaroylamino in position 3 and their use as pharmaceuticals | |
| IL249826A0 (en) | Propionic acid derivatives converted in 3-heteroylamino and their use in pharmaceutical preparations | |
| GB201111630D0 (en) | Novel compounds and their use | |
| GB201111775D0 (en) | Compounds and uses thereof | |
| GB201114448D0 (en) | Compounds and their use | |
| EP2782571A4 (fr) | Composés hétérocycliques et leurs utilisations | |
| IL231096A (en) | Theses are converted into 2- (novel-6-Iloxy) and used as pharmaceutical preparations | |
| PH12014500542A1 (en) | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals | |
| IL232809A0 (en) | Carboxamides converted at position 2 in isothiazolopyridine and their use as medicinal preparations | |
| GB201104444D0 (en) | Compounds and their use | |
| GB201121726D0 (en) | Compounds and uses thereof | |
| GB201121551D0 (en) | Compounds and uses thereof | |
| GB201213726D0 (en) | Novel compounds and their use |